Pretreatment HIV drug resistance in low-and middle-income countries

Autor: Inzaule, SC, Hamers, RL, Bertagnolio, S, Siedner, MJ, De Wit, TFR, Gupta, RK

Pretreatment HIV drug resistance (PDR) has been increasing with scale-up of antiretroviral therapy (ART) in low- and middle-income countries. Delay in responding to rising levels of PDR is projected to fuel a worldwide increase in mortality, HIV inci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6c19eccef15ea1147c86babe350d957
https://www.repository.cam.ac.uk/handle/1810/298241

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study

Autor: Inzaule, SC, Hamers, R, Kityo, C, Rinke de Wit, TF, Roura, M, Isaakidis, P

Publikováno v: PLoS ONE, Vol 11, Iss 11, p e0167492 (2016)
PLoS ONE
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
PLoS ONE, 11(11). Public Library of Science

Background Long-term success of HIV antiretroviral therapy requires near-perfect adherence, maintained throughout one’s lifetime. However, perceptions towards ART and patterns of adherence may change during the life course. We assessed challenges t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4447bb5fdb145db4532ff2937cff0440
http://hdl.handle.net/2445/104552

Recommendations on data sharing in HIV drug resistance research.

Autor: Inzaule SC; Amsterdam Institute for Global Health and Development, and Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Siedner MJ; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America., Little SJ; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, California, United States of America., Avila-Rios S; Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico., Ayitewala A; National Health Laboratories and Diagnostic Services, Ministries of Health, Kampala, Uganda., Bosch RJ; Center for Biostatistics in AIDS Research, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America., Calvez V; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France., Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy., Charpentier C; Service de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, F-75018 Paris, France., Descamps D; Service de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, F-75018 Paris, France., Eshleman SH; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America., Fokam J; Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon, and Faculty of Health Sciences, University of Buea, Yaoundé, Cameroon., Frenkel LM; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America., Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, United Kingdom., Ioannidis JPA; Department of Medicine, Department of Epidemiology and Population Health, and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, United States of America., Kaleebu P; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Entebbe, Uganda., Kantor R; Department of Medicine, Brown University, The Miriam Hospital, Providence, Rhode Island, United States of America., Kassaye SG; Department of Medicine, Division of Infectious Diseases, Georgetown University, Washington DC, United States of America., Kosakovsky Pond SL; Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, Pennsylvania, United States of America., Kouamou V; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe., Kouyos RD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland and Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Kuritzkes DR; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Lessells R; Affiliation is KwaZulu-Natal Research Innovation & Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa., Marcelin AG; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France., Mbuagbaw L; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada., Minalga B; Office of HIV/AIDS Network Coordination, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Ndembi N; Institute of Human Virology Nigeria, Herbert Macaulay Way, Abuja, Nigeria., Neher RA; Biozentrum, University of Basel, Basel, Switzerland., Paredes R; Department of Infectious Diseases & irsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain., Pillay D; Division of Infection and Immunity, University College London, London, United Kingdom., Raizes EG; United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Rhee SY; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California, United States of America., Richman DD; Center for AIDS Research, Department of Medicine, University of California San Diego, San Diego, California, United States of America., Ruxrungtham K; School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Sabeti PC; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America., Schapiro JM; National Hemophilia Center, Sheba Medical Center, Ramat Gan, Israel., Sirivichayakul S; Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Steegen K; Department of Molecular Medicine and Haematology, National Health Laboratory Service, Johannesburg, South Africa., Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., van Zyl GU; Division of Medical Virology, Stellenbosch University and National Health Laboratory Service, Cape Town, South Africa., Vandamme AM; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium.; Center for Global Health And Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal., Wensing AMJ; University Medical Center Utrecht, the Netherlands and Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa., Wertheim JO; Department of Medicine, University of California San Diego, San Diego, La Jolla, California, United States of America., Gunthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland and Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Jordan MR; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America., Shafer RW; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California, United States of America.

Publikováno v: PLoS medicine [PLoS Med] 2023 Sep 22; Vol. 20 (9), pp. e1004293. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023).

Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria.

Autor: Anejo-Okopi J; Department of Microbiology, University of Jos, Jos, Nigeria.; AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos, Nigeria., Okeke E; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Davwar PM; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Onwuamah C; Center for Human Virology and Genomics Nigeria Institute of Medical Research, Lagos, Nigeria., Onywera H; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.; Research, Innovations, and Academics Unit, Tunacare Services Health Providers Limited, Nairobi, Kenya., Omaiye P; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Duguru M; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Okojokwu OJ; Department of Microbiology, University of Jos, Jos, Nigeria., Ujah OI; Department of Community and Family Health, College of Public Health, University of South Florida, Tampa, Florida, United States., Jonathan B; Department of Family Medicine, Plateau State Specialist Hospital, Jos, Nigeria., George CA; Department of Family Medicine, Bingham University Teaching Hospital, Jos, Nigeria., Crown RS; Department of Medical Microbiology and Parasitology, Bingham University Teaching Hospital, Jos, Nigeria., Yakubu FB; Department of Chemical Pathology, Jos University Teaching Hospital, Jos, Nigeria., Sokei JO; Center for Human Virology and Genomics Nigeria Institute of Medical Research, Lagos, Nigeria., Okoli LC; Center for Human Virology and Genomics Nigeria Institute of Medical Research, Lagos, Nigeria., Audu O; Department of Epidemiology and Community Health, Benue State University, Makurdi, Nigeria., Inzaule SC; Department of HIV and Global Hepatitis Program, World Health Organization, Geneva, Switzerland., Abah IO; Department of Pharmacology, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Agaba P; AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos, Nigeria.; Department of Family Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Agbaji OO; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Sagay AS; Department of Obstetrics and Gynaecology, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Hawkins C; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.

Publikováno v: African journal of laboratory medicine [Afr J Lab Med] 2022 Oct 18; Vol. 11 (1), pp. 1677. Date of Electronic Publication: 2022 Oct 18 (Print Publication: 2022).

Impact of nucleos(t)ide reverse transcriptase inhibitor resistance on dolutegravir and protease-inhibitor-based regimens in children and adolescents in Kenya.

Autor: Kingwara L; National AIDS and STI Control Programme.; National Laboratory Services, Ministry of Health, Nairobi, Kenya., Inzaule SC; Amsterdam Institute for Global Health and Development, and Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Momanyi L; National AIDS and STI Control Programme., Jordan MR; Levey Center for Integrated Management of Antimicrobial Resistance, Tufts University School of Medicine.; Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA, USA., Nyanya W; National AIDS and STI Control Programme., Bowen N; National Laboratory Services, Ministry of Health, Nairobi, Kenya., Oramisi V; National AIDS and STI Control Programme., Kiiru JN; National Laboratory Services, Ministry of Health, Nairobi, Kenya., Ngugi C; National AIDS and STI Control Programme.

Publikováno v: AIDS (London, England) [AIDS] 2022 Mar 15; Vol. 36 (4), pp. 611-613.